MedPath

Evaluation of Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol for In vitro Fertilization in Women with Polycystic Ovary Syndrome

Phase 3
Completed
Conditions
Infertility.
Female infertility
Registration Number
IRCT20091018002604N6
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
150
Inclusion Criteria

Women with Polycystic Ovary Syndrome (PCOS) candidate for ART(Assisted Reproductive Techniques)
Age in range of 20-40 years
BMI in range of 20-30 kg/m2

Exclusion Criteria

Sever endometriosis
Sever male factor infertility
Pelvic neoplasia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of M II oocytes. Timepoint: After ovarian puncture. Method of measurement: Microscopic manual counting by embryologist.
Secondary Outcome Measures
NameTimeMethod
The number of embryos with qualities of A,B,or C. Timepoint: 1-2 days after ovarian puncture. Method of measurement: Microscopic manual counting by embryologist.;The duration of controlled ovarian stimulation period. Timepoint: Immediatly after controlled ovarian stimulation. Method of measurement: Time scale(day).;The dosage of Gonadotropin used. Timepoint: After controlled ovarian stimulation. Method of measurement: Counting.;The number of Cetrotide injections. Timepoint: After controlled ovarian stimulation. Method of measurement: Counting.;The incidence of OHSS(Ovarian Hyperstimulation Syndrome). Timepoint: 3_7 days after trigger. Method of measurement: Through phisycal examination and Ultra sonography.
© Copyright 2025. All Rights Reserved by MedPath